Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land?

Abbott, R (2014) Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land? FDLI's Food and Drug Policy Forum, 4 (10). pp. 1-14.

Full text not available from this repository.

Abstract

This article argues that an administrative bounty proceeding should be established to motivate third parties to submit data on drug safety and efficacy to the food and drug agency. The administrative bounty proceeding should be modeled after the Federal Claims Act qui tam regime, and the federal government should pay petitioner rewards based on a portion of the money that the government will save by avoiding adverse effects and medically ineffective therapies in patients with government health insurance.

Item Type:	Article
Subjects :	Law
Divisions :	Faculty of Arts and Social Sciences > School of Law
Authors :	Name Email ORCID Abbott, R r.abbott@surrey.ac.uk
Date :	29 October 2014
Copyright Disclaimer :	Copyright 2014 Food and Drug Law Insititute
Related URLs :	Publisher
Depositing User :	Symplectic Elements
Date Deposited :	16 May 2017 15:37
Last Modified :	04 Dec 2019 16:09
URI:	http://epubs.surrey.ac.uk/id/eprint/820931

Actions (login required)

View Item

Downloads